Your browser doesn't support javascript.
loading
Palliative psychiatry for a patient with treatment-refractory schizophrenia and severe chronic malignant catatonia: case report.
Elgudin, Junona; Johnsen, Clark; Westermair, Anna Lisa; Trachsel, Manuel.
Afiliação
  • Elgudin J; Department of Psychiatry, New York-Presbyterian/Weill Cornell Medicine, New York, NY, USA.
  • Johnsen C; Department of Psychiatry, Weill Cornell Medicine, New York, NY, USA.
  • Westermair AL; Clinical Ethics Unit, University Hospital Basel (USB), University Psychiatric Clinics (UPK) Basel, University Children's Hospital Basel (UKBB), Geriatric University Medicine Felix Platter (UAFP), Basel, Switzerland; Institute of Biomedical Ethics and History of Medicine (IBME), University of Zurich
  • Trachsel M; Clinical Ethics Unit, University Hospital Basel (USB), University Psychiatric Clinics (UPK) Basel, University Children's Hospital Basel (UKBB), Geriatric University Medicine Felix Platter (UAFP), Basel, Switzerland; Medical Faculty, University of Basel, Basel, Switzerland.
Ann Palliat Med ; 13(2): 433-439, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38509645
ABSTRACT

BACKGROUND:

Palliative psychiatry is an emerging field that suggests a role for palliative interventions in the management of severe and persistent mental illness (SPMI). Current literature describes using a palliative approach for patients with severe anorexia nervosa. To our knowledge, this is the first case report describing end-of-life care in a patient with treatment-refractory catatonic schizophrenia. CASE DESCRIPTION We describe the case of a 49-year-old man with schizophrenia and severe chronic agitated/malignant catatonia who was hospitalized for ten months. Multiple treatment trials including medication such as neuroleptics and benzodiazepines, electroconvulsive therapy, and empiric interventions such as intravenous immunoglobulins were either not tolerated or did not result in clinically significant improvement. The patient continued to intermittently require intubation and sedation to control intractable behavioral and psychiatric disturbances. Ultimately, with collaboration of psychiatry, neurology, ethics, intensive care, and palliative care teams, the patient's parents decided to forgo further diagnostic testing and life-sustaining treatments. The patient died weeks later of aspiration pneumonia with good symptom control.

CONCLUSIONS:

This case permits discussion of palliative interventions in patients with SPMI such as treatment-refractory psychotic disorders who likely cannot achieve a quality of life that is acceptable to them. Here, it can be justified to prioritize relief of suffering and prevention of further burdensome interventions over treatment of the SPMI symptoms such as catatonia and even over keeping the patient alive.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psiquiatria / Esquizofrenia / Catatonia Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psiquiatria / Esquizofrenia / Catatonia Idioma: En Ano de publicação: 2024 Tipo de documento: Article